ArticleJournal of applied toxicology : JAT2026
Bile Acid Glycochenodeoxycholic Acid (GCDCA) Might Induce the Loss of Plasma Membrane Integrity and the Release of LDH From Ovarian Granulosa Cells, With Implications in PCOS.
Article in Journal of applied toxicology : JAT, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Pathogenic mechanisms and comprehensive therapeutic strategies of ovarian aging: targeting gut microbiota.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Altered bile acid profiles in the follicular fluid have been implicated in the pathogenesis of PCOS. Whether certain bile acids modulate the lytic death of ovarian granulosa cells following regulated cell death mechanisms such as pyroptosis and necroptosis in the context of PCOS is unknown. We here treated ovarian granulosa cells (KGN cell line) with different concentrations of three bile acids (GCDCA, TCA, and GCA) in vitro, and then comparatively analyzed the levels of IL-18, LDH, and PGE2 released from these cells by performing ELISA experiments, in order to determine if these bile acids lead to the loss of plasma membrane integrity in granulosa cells. We found that GCDCA (glycochenodeoxycholic acid) at a concentration of 2500 nmol/L significantly increases the release of LDH from KGN cells in vitro. At this concentration, GCDCA treatment resulted in higher than 30% increased release of LDH from granulosa cells. This bile acid-induced increases in LDH release from granulosa cells were specific to GCDCA, because two other bile acids (TCA (taurocholic acid) and GCA (glycocholic acid)) failed to significantly induce the release of LDH from KGN cells. Further mechanistic studies are needed to determine which plasma membrane rupture mechanisms are mostly involved in LDH release from granulosa cells upon GCDCA treatment. For instance, NINJ1-KO and SIGLEC12-KO KGN cells should be used to see in which case GCDCA fails to induce the release of LDH from granulosa cells, and to identify molecular players involved in bile acid-induced lytic cell death-associated membrane rupture in granulosa cells in the context of PCOS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.